Table 3.
Univariate and multivariate proportional hazards (Cox) regression analyses according to OS.
Univariate Cox analysis | Multivariate Cox analysis | |||
Variables in the equation | P | Hazard ratio (95% CI) | P | Hazard ratio (95.0% CI) |
Age | ||||
<57 | – | – | ||
>57 | .360 | 0.793 (0.483–1.303) | ||
Gender | ||||
Male | – | – | ||
Female | .572 | 0.865 (0.523–1.430) | ||
Smoke status | ||||
Never | – | – | ||
Smoker | .946 | 1.020 (0.572–1.818) | ||
Histology | ||||
ADC | – | – | ||
Others | .462 | 0.745 (0.340–1.633) | ||
TNM stage | ||||
III | – | – | – | – |
IV | .020 | 2.326 (1.145–4.724) | 0.043 | 2.096 (1.022–4.299) |
PLR | ||||
<172.88 | – | – | ||
>172.88 | .053 | 1.621 (0.993–2.646) | ||
MLR | ||||
<0.23 | – | – | ||
>0.23 | .055 | 1.690 (0.989–2.887) | ||
NLR | ||||
<2.72 | – | – | ||
>2.72 | .140 | 1.469 (0.881–2.448) | ||
SII | ||||
<841.03 | – | – | – | – |
>841.03 | .017 | 1.817 (1.114–2.961) | 0.049 | 1.644 (1.002–2.696) |
Drug | ||||
Icotinib | .322 | – | ||
Erlotinib | .141 | 0.509 (0.207–1.251) | ||
Gefitinib | .324 | 0.742 (0.411–1.341) |